Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.
The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.
Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.
Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Depressive Disorders market in Africa is experiencing significant growth and development due to several factors.
Customer preferences: In recent years, there has been a growing awareness and understanding of mental health issues in Africa. As a result, there is an increasing demand for effective treatments and therapies for depressive disorders. Customers are seeking out healthcare providers and products that can address their mental health needs and improve their overall well-being.
Trends in the market: One of the key trends in the Depressive Disorders market in Africa is the adoption of telemedicine and online therapy platforms. These platforms provide convenient and accessible mental health services to individuals who may not have easy access to traditional healthcare facilities. The use of technology has helped to bridge the gap in mental healthcare services and reach a wider population. Another trend in the market is the integration of traditional African healing practices with modern medical approaches. Many individuals in Africa still rely on traditional healers and herbal remedies for treating mental health conditions. As a result, there is a growing interest in combining traditional practices with evidence-based treatments for depressive disorders. This integration of different treatment modalities is driving innovation in the market and providing more options for patients.
Local special circumstances: Africa is a diverse continent with a wide range of cultures, languages, and healthcare systems. Each country in Africa has its own unique set of challenges and opportunities in addressing mental health issues. For example, in some countries, there may be a lack of mental healthcare infrastructure and professionals, while in others, there may be cultural stigmas surrounding mental health. These local special circumstances influence the availability and accessibility of treatments for depressive disorders.
Underlying macroeconomic factors: The economic development and growth in Africa are also contributing to the development of the Depressive Disorders market. As countries in Africa experience economic growth, there is an increase in disposable income and healthcare spending. This allows individuals to seek out and afford mental healthcare services. Additionally, the expansion of healthcare insurance coverage in some countries is also driving the demand for mental health treatments.In conclusion, the Depressive Disorders market in Africa is developing due to increasing customer preferences for mental health treatments, the adoption of telemedicine and integration of traditional healing practices, local special circumstances that influence the availability of treatments, and underlying macroeconomic factors such as economic growth and healthcare insurance coverage. The market is expected to continue growing as more individuals recognize the importance of mental health and seek out appropriate treatments and therapies.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights